Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 29

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 29
---
 |   186,988 |     | *          |
| Craig Johnson(10)                        |     | Director                             |     |            |    71,804 |     | *          |
| Michael Kaseta(11)                       |     | Director                             |     |            |    20,189 |     | *          |
| Adam Morgan(12)                          |     | Chairman of the Board                |     |            | 7,643,427 |     | 4.99%      |
| Susan Rodriguez(13)                      |     | Director                             |     |            |    76,385 |     | *          |
| Christian Waage(14)                      |     | Director                             |     |            |    72,164 |     | *          |
| Current Executive Officers and Directors 
 as a group (10 persons) (15)             |     |                                      |     |            | 9,005,835 |     | 5.86%      |

* Indicates ownership of less than one percent. (1) As applicable, the number of shares of common stock listed as owned by a beneficial holder relies on public filings by such beneficial holder and the number of shares of common stock reported as beneficially owned.

21

Based on information set forth in a Schedule 13D/A filed with the SEC on May 31, 2024 by Rubric Capital Management LP and David Rosen. Mr. Rosen is the Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital Management LP. The Schedule 13D/A indicates that Rubric Capital Management LP and David Rosen have shared voting and dispositive power with respect to 26,713,503 shares of common stock.

Based on information set forth in a Schedule 13G filed with the SEC on November 12, 2024 by Adage Capital Management, L.P., Robert Atchinson and Phillip Gross. Mr. Atchinson and Mr. Gross are the Managing Members of Adage Capital Partners LLC, the general partner of Adage Capital Management, L.P. The Schedule 13G indicates that Adage Capital Management, L.P., Robert Atchinson and Phillip Gross have shared voting and dispositive power with respect to the 8,850,000 shares of common stock.

Based on information set forth in a Schedule 13G filed with the SEC on November 8, 2024 by Blackrock, Inc. reporting beneficial ownership of 8,534,567 shares of common